Gastritis

Endoscopic Findings of Gastritis in Children

Retrospective Study on Endoscopic Findings of Gastritis in Children Attending GIT Endoscopic Unit of Assiut University Children Hospital (AUCH) (15 Years)

infections
inflammation
Helicobacter pylori
Acute erosive gastritis

HM Reyad

principle investigator

Assiut University

Irritable Bowel Syndrome

Inflammatory Bowel Diseases

1) Patients scheduled for endoscopy (EGD or colonoscopy) for IBD will be consented to allow physicians who are performing endoscopies to take additional biopsies and blood samples for "research purposes".

Biopsies from endoscopy

University of Arkansas for Medical Sciences

Mucosal Innate Immune Activation in Chronic Intestinal Disorders

Determining the level of mucosal innate immune activation by staining, organoid culture, Western blot analysis, and cytokine expression on biopsy samples in IBD and IBS patient samples.

University of Arkansas

Each patient will undergo mastectomy(ies) if immediate reconstruction is being performed, followed by uni- or bilateral abdominally based free flap harvest, microsurgical anastomoses, and flap inset. If randomized to the ketorolac intervention group, then the participant will receive 30 mg of intravenous (IV) ketorolac tromethamine. The anaesthetist will give participants their first study drug intravenously at the conclusion of surgery. The participant will then continue to receive their assigned drug every 6 hours for 72 hours, for a total of 13 doses. Patients all receive 1:1 care from nursing staff in the early postoperative period, and their nurse will administer all drugs given on the surgical ward.

Each patient will undergo mastectomy(ies) if immediate reconstruction is being performed, followed by uni- or bilateral abdominally based free flap harvest, microsurgical anastomoses, and flap inset. If randomized to the control group the patient will be given a sham IV medication. The sham medication will be normal saline at the same volume as ketorolac, which corresponds to 3 ccs. The anaesthetist will give participants their first study drug intravenously at the conclusion of surgery. The participant will then continue to receive their assigned drug every 6 hours for 72 hours, for a total of 13 doses. Patients all receive 1:1 care from nursing staff in the early postoperative period, and their nurse will administer all drugs given on the surgical ward.

Breast Cancer Female

Ketorolac Tromethamine

Normal Saline

Ketorolac for Analgesia followiNG Autologous Breast RecOnstructiOn

recorded in days beginning post operative day number one

Total narcotic consumption over first 72 hours converted to morphine equivalence

Total surgical drain output over first 72 hours

Any hematoma requiring management in the operating room

Any infection requiring antibiotics, or flap complications requiring management in the operating room

Joey Corkum

Physician

Nova Scotia Health Authority

Bovine lactoferrin orally - 100 mg twice a day, for whole antibiotic treatment period.

Maltodextrin orally - 100 mg twice a day, for whole antibiotic treatment period.

Antibiotic Associated Diarrhoea

The children will be randomly assigned to receive 100 mg of bovine lactoferrin twice a day orally for the whole period of antibiotic therapy.

Bovine lactoferrin

The children will be randomly assigned to receive 100 mg of placebo - maltodextrin twice a day orally for the whole period of antibiotic therapy.

Maltodextrin

Medical University of Warsaw's Department of Paediatric Gastroenterology and Nutrition

Bovine Lactoferrin and Antibiotic-associated Diarrhoea.

Bovine Lactoferrin in the Prevention of Antibiotic-associated Diarrhoea in Children - a Randomized Clinical Trial.

Occurrence of diarrhea up to 24 days after initiation of antibiotic treatment, defined as > 3 stools a day, a watery or loose stool with/or occurrence of blood in the stool.

Medical University of Warsaw

Pharmabest Sp. z o.o.

Hemorrhage

Anemia

Ferrous sulfate 325mg by mouth twice daily for the duration of the 12 month follow up period

Ferrous sulfate

Capsule Endoscopy

Medical University of South Carolina

Capsule Endoscopy Versus Conservative Therapy for Obscure Gastrointestinal Bleeding

Time-to-event analysis. Patients will be provided an index card on which they will record the date of their first blood transfusion after randomization

• Group 1: Naproxen 500 mg twice daily for three weeks following surgery beginning postoperative day #1

• Group 2: Placebo twice daily for three weeks following surgery beginning postoperative day #1

Heterotopic Ossification

Naproxen

placebo

University of Utah Orthopedics Center

Influence of Naproxen on Heterotropic Bone Formation Following Hip Arthroscopy

The hypothesis is that there will be fewer instances of HO in the Naproxen group compared to the Placebo group.

Adverse events include GI upset, GI bleed, Kidney failure, Drug reactions and Healing problems.

Stephen Aoki

M.D.

University of Utah

Infants with bowel resection who will receive the oral rotavirus vaccine, RotaTeq(R).

Healthy infants that are gest. age and age-matched controls within 14 days will be given the oral rotavirus vaccine, RotaTeq(R).

Infants with bowel resection who will receive the oral rotavirus vaccine, RotaTeq(R).
Oral, live, pentavalent rotavirus vaccine; RotaTeq(R): Oral vaccine for prevention of rotavirus infection, 3 dose series

Infants With Bowel Resection

Healthy infants that are gest. age and age-matched controls within 14 days will be given the oral rotavirus vaccine, RotaTeq(R).
Oral, live, pentavalent rotavirus vaccine; RotaTeq(R): Oral vaccine for prevention of rotavirus infection, 3 dose series

Healthy Infants

Total

Age, Customized

Sex: Female, Male

Region of Enrollment

Pre-vaccination serum IgA antirotavirus titer

Rotavirus Anti-Immunoglobulin A (IgA) serum antibody level

Adverse events and patient tolerance of vaccine doses 1 - 3 for all infants participating in the study were recorded.

Safety and Tolerability of the Oral RotaTeq® Vaccine

Serum anti-rotavirus IgA level was measured post-vaccination in all subjects

Serum Anti-rotavirus IgA Level Post-vaccination

Overall Study

Eric McGrath, MD

Short Bowel Syndrome

Oral vaccine for prevention of rotavirus infection, 3 dose series

melena/diarrhea